A proposed methodology to determine the final cost of an inpatient drug
Objective: To design a methodology to assess the impact of processes in the value chain of costs billed to third-party payors for drugs with greater participation in the total turnover of a health institution. Methodology: It was based on the theory of value chain, defined by Michael Porter. To this...
| Autor Principal: | Cano Botero, Daniela |
|---|---|
| Otros Autores: | Carranza Mojica, Diana, Universidad Jorge Tadeo Lozano, Mojica Martínez, Aura María, Núñez Antolinez, Marisol, Pedraza Muñoz, Lucy Paola, Jiménez Barbosa, Wilson Giovanni |
| Formato: | info:eu-repo/semantics/article |
| Idioma: | spa |
| Publicado: |
Universidad de La Salle. Revistas. Ciencia y Tecnología para la Salud Visual y Ocular.
2016
|
| Materias: | |
| Acceso en línea: |
http://revistas.lasalle.edu.co/index.php/sv/article/view/3512 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: |
Objective: To design a methodology to assess the impact of processes in the value chain of costs billed to third-party payors for drugs with greater participation in the total turnover of a health institution. Methodology: It was based on the theory of value chain, defined by Michael Porter. To this effect, by analyzing information reported by the health service provider institution (IPS), a first documentary stage established the drugs with greater participation in billing, through the Pareto principle. Results: Based on the analysis of the processes in the value chain of hospital drugs, a formula was proposed to identify those with the most influence on the final cost. Conclusions: Based on the analysis of all processes in the value chain, this methodologically sound formula constitutes a tool that allows to take actions for a continuous improvement, leading to cost reduction and the generation of added value. |
|---|